Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA episode artwork

EPISODE · Jul 31, 2025 · 31 MIN

Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA

from The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. · host Sykes & Company, P.A.

Send us Fan MailSchedule an Rx AssessmentSubscribe to Master The MarginH.R. 4317, PBM transparency and Medicare drug pricing...The legislative landscape is shifting fast, and if pharmacy owners want a sustainable future, advocacy can’t be optional.So where do things stand and what’s next?In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with B. Douglas Hoey, CEO of the NCPA, to discuss:- What the PBM Reform Act means for pharmacy reimbursement- How Medicare drug pricing changes will impact your margins- Why advocacy doesn’t stop after a legislative winAnd more!More About Our Guest:Douglas Hoey is the Chief Executive Officer of the National Community Pharmacists Association. NCPA represents the owners of nearly 20,000 pharmacy small businesses who’s pharmacists provide prescription dispensing services and help fill primary care gaps. The majority of these pharmacies are located in areas the CDC ranks as “high” or “very high” on the Socially Vulnerable Index. Consumers consistently rank community pharmacies as the top-rated pharmacies in the country. Hoey is a licensed pharmacist in Oklahoma, Virginia, and Texas and practiced in community pharmacies including his family’s pharmacy before coming to NCPA. He is widely quoted by media as an industry expert on community pharmacy payment and practice issues. Hoey also developed and taught pharmacology courses at George Washington and Marymount universities. He is President of the World Pharmacy Council, co-Chairman of the Board of Directors for Surescripts, Chairman of the NCPA Innovation Center, and co-Chairman of the CPESN-USA Board. His pharmacy degree is from the University of Oklahoma and his MBA is from the Oklahoma City University. Learn more about Doug and the NCPA:Doug Hoey LinkedInNCPA FacebookNCPA InstagramNCPA LinkedInNCPA YouTubeNCPA Twitter (X)NCPA WebsiteStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - The Trusted Pharmacist: Advocacy and Building a Resilient Pharmacy

Episode metadata supplied by the publisher feed · Published Jul 31, 2025

Embed this episode

Send us Fan Mail Schedule an Rx Assessment Subscribe to Master The Margin H.R. 4317, PBM transparency and Medicare drug pricing...The legislative landscape is shifting fast, and if pharmacy owners want a sustainable future, advocacy can’t be optional. So where do things stand and what’s next? In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with B. Douglas Hoey, CEO of the NCPA, to discuss: - What the PBM Reform Act means for pha...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA

0:00 31:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.?

This episode is 31 minutes long.

When was this The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. episode published?

This episode was published on July 31, 2025.

Can I download this The Bottom Line Pharmacy Podcast: Sykes & Company, P.A. episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!